| Year |
Citation |
Score |
| 2024 |
Slick RA, Sutton J, Haberman M, O'Brien BS, Tinklenberg JA, Mardikar A, Prom MJ, Beatka M, Gartz M, Vanden Avond M, Siebers E, Mack DL, Gonzalez JP, Ebert AD, Nagaraju K, ... Lawlor MW, et al. High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy. Biology Open. PMID 39158383 DOI: 10.1242/bio.060542 |
0.4 |
|
| 2024 |
Karimi E, Gohlke J, van der Borgh M, Lindqvist J, Hourani Z, Kolb J, Cossette S, Lawlor MW, Ottenheijm C, Granzier H. Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects. Acta Neuropathologica. 147: 72. PMID 38634969 DOI: 10.1007/s00401-024-02726-w |
0.372 |
|
| 2023 |
Karimi E, van der Borgh M, Lindqvist J, Gohlke J, Hourani Z, Kolb J, Cossette S, Lawlor MW, Ottenheijm C, Granzier H. Characterization of mutations in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects. Biorxiv : the Preprint Server For Biology. PMID 38187705 DOI: 10.1101/2023.12.20.572678 |
0.421 |
|
| 2023 |
Lawlor MW, Schoser B, Margeta M, Sewry CA, Jones KA, Shieh PB, Kuntz NL, Smith BK, Dowling JJ, Müller-Felber W, Bönnemann CG, Seferian AM, Blaschek A, Neuhaus S, Foley AR, et al. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial. Ebiomedicine. 99: 104894. PMID 38086156 DOI: 10.1016/j.ebiom.2023.104894 |
0.618 |
|
| 2023 |
Shieh PB, Kuntz NL, Dowling JJ, Müller-Felber W, Bönnemann CG, Seferian AM, Servais L, Smith BK, Muntoni F, Blaschek A, Foley AR, Saade DN, Neuhaus S, Alfano LN, Beggs AH, ... ... Lawlor MW, et al. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial. The Lancet. Neurology. 22: 1125-1139. PMID 37977713 DOI: 10.1016/S1474-4422(23)00313-7 |
0.535 |
|
| 2023 |
Slick RA, Tinklenberg JA, Sutton J, Zhang L, Meng H, Beatka M, Avond MV, Prom MJ, Ott E, Montanaro F, Heisner J, Toro R, Granzier H, Geurts AM, Stowe D, ... ... Lawlor MW, et al. Aberrations in Energetic Metabolism and Stress-Related Pathways Contribute to Pathophysiology in the Neb Conditional Knockout Mouse Model of Nemaline Myopathy. The American Journal of Pathology. PMID 37422147 DOI: 10.1016/j.ajpath.2023.06.009 |
0.376 |
|
| 2023 |
Tinklenberg JA, Slick RA, Sutton J, Zhang L, Meng H, Beatka MJ, Avond MV, Prom MJ, Ott E, Montanaro F, Heisner J, Toro R, Hardeman EC, Geurts AM, Stowe D, ... ... Lawlor MW, et al. Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology. The American Journal of Pathology. PMID 37419385 DOI: 10.1016/j.ajpath.2023.06.008 |
0.378 |
|
| 2023 |
Gartz M, Haberman M, Sutton J, Slick RA, Luttrell SM, Mack DL, Lawlor MW. ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy. Experimental Cell Research. 424: 113507. PMID 36796746 DOI: 10.1016/j.yexcr.2023.113507 |
0.375 |
|
| 2023 |
Birch SM, Lawlor MW, Conlon TJ, Guo LJ, Crudele JM, Hawkins EC, Nghiem PP, Ahn M, Meng H, Beatka MJ, Fickau BA, Prieto JC, Styner MA, Struharik MJ, Shanks C, et al. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815. PMID 36599002 DOI: 10.1126/scitranslmed.abo1815 |
0.361 |
|
| 2022 |
Boehler JF, Brown KJ, Beatka M, Gonzalez JP, Donisa Dreghici R, Soustek-Kramer M, McGonigle S, Ganot A, Palmer T, Lowie C, Chamberlain JS, Lawlor MW, Morris CA. Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscular Disorders : Nmd. PMID 36575103 DOI: 10.1016/j.nmd.2022.12.007 |
0.311 |
|
| 2022 |
Dowling JJ, Müller-Felber W, Smith BK, Bönnemann CG, Kuntz NL, Muntoni F, Servais L, Alfano LN, Beggs AH, Bilder DA, Blaschek A, Duong T, Graham RJ, Jain M, Lawlor MW, et al. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy. Journal of Neuromuscular Diseases. PMID 35694931 DOI: 10.3233/JND-210781 |
0.492 |
|
| 2022 |
Gartz M, Haberman M, Prom MJ, Beatka MJ, Strande JL, Lawlor MW. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 27: 10742484221088655. PMID 35353647 DOI: 10.1177/10742484221088655 |
0.421 |
|
| 2021 |
Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F. Muscle-directed gene therapy corrects Pompe disease and uncovers species-specific GAA immunogenicity. Embo Molecular Medicine. e13968. PMID 34850579 DOI: 10.15252/emmm.202113968 |
0.374 |
|
| 2021 |
Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, et al. Erratum: Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. Molecular Therapy. Methods & Clinical Development. 23: 460. PMID 34820472 DOI: 10.1016/j.omtm.2021.10.005 |
0.363 |
|
| 2021 |
Lawlor MW, Dowling JJ. X-linked myotubular myopathy. Neuromuscular Disorders : Nmd. 31: 1004-1012. PMID 34736623 DOI: 10.1016/j.nmd.2021.08.003 |
0.448 |
|
| 2021 |
Molera C, Sarishvili T, Nascimento A, Rtskhiladze I, Muñoz Bartolo G, Fernández Cebrián S, Valverde Fernández J, Muñoz Cabello B, Graham RJ, Miller W, Sepulveda B, Kamath BM, Meng H, Lawlor MW. Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report. Journal of Neuromuscular Diseases. PMID 34366366 DOI: 10.3233/JND-210712 |
0.345 |
|
| 2021 |
Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, et al. Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. Molecular Therapy. Methods & Clinical Development. 21: 144-160. PMID 33850950 DOI: 10.1016/j.omtm.2021.02.024 |
0.385 |
|
| 2021 |
Amburgey K, Acker M, Saeed S, Amin R, Beggs AH, Bönnemann CG, Brudno M, Constantinescu A, Dastgir J, Diallo M, Genetti CA, Glueck M, Hewson S, Hum C, Jain MS, ... Lawlor MW, et al. A Cross-Sectional Study of Nemaline Myopathy. Neurology. PMID 33397769 DOI: 10.1212/WNL.0000000000011458 |
0.413 |
|
| 2020 |
Hall A, Fontelonga T, Wright A, Bugda Gwilt K, Widrick J, Pasut A, Villa F, Miranti CK, Gibbs D, Jiang E, Meng H, Lawlor MW, Gussoni E. Tetraspanin CD82 is necessary for muscle stem cell activation and supports dystrophic muscle function. Skeletal Muscle. 10: 34. PMID 33243288 DOI: 10.1186/s13395-020-00252-3 |
0.362 |
|
| 2020 |
Ross JA, Tasfaout H, Levy Y, Morgan J, Cowling BS, Laporte J, Zanoteli E, Romero NB, Lowe DA, Jungbluth H, Lawlor MW, Mack DL, Ochala J. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy. Acta Neuropathologica Communications. 8: 167. PMID 33076971 DOI: 10.1186/s40478-020-01048-8 |
0.455 |
|
| 2020 |
Nuckolls GH, Kinnett K, Dayanidhi S, Domenighetti AA, Duong T, Hathout Y, Lawlor MW, Lee S, Magnusson SP, McDonald CM, McNally EM, Miller NF, Olwin BB, Raghavan P, Roberts T, et al. Conference Report on Contractures in Musculoskeletal and Neurological Conditions. Muscle & Nerve. PMID 32108365 DOI: 10.1002/Mus.26845 |
0.382 |
|
| 2020 |
Laitila JM, McNamara EL, Wingate CD, Goullee H, Ross JA, Taylor RL, van der Pijl R, Griffiths LM, Harries R, Ravenscroft G, Clayton JS, Sewry C, Lawlor MW, Ottenheijm CAC, Bakker AJ, et al. Nebulin nemaline myopathy recapitulated in a compound heterozygous mouse model with both a missense and a nonsense mutation in Neb. Acta Neuropathologica Communications. 8: 18. PMID 32066503 DOI: 10.1186/s40478-020-0893-1 |
0.374 |
|
| 2019 |
Dupont JB, Guo J, Renaud-Gabardos E, Poulard K, Latournerie V, Lawlor MW, Grange RW, Gray JT, Buj-Bello A, Childers MK, Mack DL. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31784415 DOI: 10.1016/j.ymthe.2019.10.018 |
0.395 |
|
| 2019 |
Helbling DC, Mendoza D, McCarrier J, Vanden Avond MA, Harmelink MM, Barkhaus PE, Basel D, Lawlor MW. Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy. Journal of Neuropathology and Experimental Neurology. PMID 30715496 DOI: 10.1093/jnen/nlz004 |
0.345 |
|
| 2019 |
Scheuermann A, Belongia M, Lawlor MW, Suchi M, Kaufman B, Vasudevaraja V, Serrano J, Snuderl M, Knipstein J. Ganglioglioma in a Survivor of Infantile Glioblastoma. Journal of Pediatric Hematology/Oncology. PMID 30676438 DOI: 10.1097/MPH.0000000000001417 |
0.406 |
|
| 2018 |
Tinklenberg JA, Siebers EM, Beatka MJ, Fickau BA, Ayres S, Meng H, Yang L, Simpson P, Granzier HL, Lawlor MW. Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO Mouse. Journal of Neuropathology and Experimental Neurology. PMID 30597051 DOI: 10.1093/jnen/nly120 |
0.334 |
|
| 2018 |
Shahnoor N, Siebers EM, Brown KJ, Lawlor MW. Pathological Issues in Dystrophinopathy in the Age of Genetic Therapies. Annual Review of Pathology. PMID 30148687 DOI: 10.1146/annurev-pathmechdis-012418-012945 |
0.351 |
|
| 2018 |
Tinklenberg J, Beatka M, Bain JL, Siebers EM, Meng H, Pearsall RS, Lawlor MW, Riley DA. Use of ankle immobilization in evaluating treatments to promote longitudinal muscle growth in mice. Muscle & Nerve. PMID 29981243 DOI: 10.1002/Mus.26296 |
0.406 |
|
| 2018 |
Fox MD, Carson VJ, Feng HZ, Lawlor MW, Gray JT, Brigatti KW, Jin JP, Strauss KA. TNNT1 nemaline myopathy: Natural history and therapeutic frontier. Human Molecular Genetics. PMID 29931346 DOI: 10.1093/hmg/ddy233 |
0.345 |
|
| 2018 |
Siebers EM, Choi MJ, Tinklenberg JA, Beatka MJ, Ayres S, Meng H, Helbling DC, Takizawa A, Bennett B, Garces AM, Dias Duarte Machado LG, Dimmock D, Dwinell MR, Geurts AM, Lawlor MW. Sdha+/- Rats Display Minimal Muscle Pathology Without Significant Behavioral or Biochemical Abnormalities. Journal of Neuropathology and Experimental Neurology. PMID 29850869 DOI: 10.1093/Jnen/Nly042 |
0.322 |
|
| 2018 |
Danièle N, Moal C, Julien L, Marinello M, Jamet T, Martin S, Vignaud A, Lawlor MW, Buj-Bello A. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice. Journal of Neuropathology and Experimental Neurology. PMID 29408998 DOI: 10.1093/jnen/nly002 |
0.457 |
|
| 2017 |
Tinklenberg JA, Siebers EM, Beatka MJ, Meng H, Yang L, Zhang Z, Ross JA, Ochala J, Morris C, Owens J, Laing NG, Nowak KJ, Lawlor MW. Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice. Human Molecular Genetics. PMID 29293963 DOI: 10.1093/hmg/ddx431 |
0.451 |
|
| 2017 |
Konersman CG, Freyermuth F, Winder TL, Lawlor MW, Lagier-Tourenne C, Patel SB. Novel autosomal dominant TNNT1 mutation causing nemaline myopathy. Molecular Genetics & Genomic Medicine. 5: 678-691. PMID 29178646 DOI: 10.1002/mgg3.325 |
0.426 |
|
| 2017 |
Elverman M, Goddard MA, Mack D, Snyder JM, Lawlor MW, Meng H, Beggs AH, Buj-Bello A, Poulard K, Marsh AP, Grange RW, Kelly VE, Childers MK. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy. Muscle & Nerve. PMID 28370029 DOI: 10.1002/Mus.25658 |
0.568 |
|
| 2017 |
Mack DL, Poulard K, Goddard MA, Latournerie V, Snyder JM, Grange RW, Elverman MR, Denard J, Veron P, Buscara L, Le Bec C, Hogrel JY, Brezovec AG, Meng H, Yang L, ... ... Lawlor MW, et al. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28237839 DOI: 10.1016/J.Ymthe.2017.02.004 |
0.565 |
|
| 2016 |
Kutchukian C, Lo Scrudato M, Tourneur Y, Poulard K, Vignaud A, Berthier C, Allard B, Lawlor MW, Buj-Bello A, Jacquemond V. Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 27911767 DOI: 10.1073/pnas.1604099113 |
0.321 |
|
| 2016 |
Alexander MS, Rozkalne A, Colletta A, Spinazzola JM, Johnson S, Rahimov F, Meng H, Lawlor MW, Estrella E, Kunkel LM, Gussoni E. CD82 Is a Marker for Prospective Isolation of Human Muscle Satellite Cells and Is Linked to Muscular Dystrophies. Cell Stem Cell. PMID 27641304 DOI: 10.1016/j.stem.2016.08.006 |
0.54 |
|
| 2016 |
Tinklenberg J, Meng H, Yang L, Liu F, Hoffmann RG, Dasgupta M, Allen KP, Beggs AH, Hardeman EC, Pearsall RS, Fitts RH, Lawlor MW. Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy. The American Journal of Pathology. PMID 27102768 DOI: 10.1016/J.Ajpath.2016.02.008 |
0.592 |
|
| 2016 |
Lawlor MW, Beggs AH, Buj-Bello A, Childers MK, Dowling JJ, James ES, Meng H, Moore SA, Prasad S, Schoser B, Sewry CA. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. Journal of Neuropathology and Experimental Neurology. PMID 26823526 DOI: 10.1093/Jnen/Nlv020 |
0.605 |
|
| 2016 |
Elverman M, Mack D, Goddard M, Snyder J, Grange R, Poulard K, Latournerie V, Veron P, Buscara L, Bec CL, Martin S, Mavilio F, Mingozzi F, Meng H, Lawlor M, et al. 498. Prolonged Benefit from Systemic rAAV8 in a Canine Model of Myotubular Myopathy Molecular Therapy. 24: S198. DOI: 10.1016/S1525-0016(16)33307-X |
0.536 |
|
| 2015 |
Goddard MA, Mack DL, Czerniecki SM, Kelly VE, Snyder JM, Grange RW, Lawlor MW, Smith BK, Beggs AH, Childers MK. Muscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy. Annals of Translational Medicine. 3: 262. PMID 26605308 DOI: 10.3978/J.Issn.2305-5839.2015.10.31 |
0.626 |
|
| 2015 |
Dastgir J, Rutkowski A, Alvarez R, Cossette SA, Yan K, Hoffmann RG, Sewry C, Hayashi YK, Goebel HH, Bonnemann C, Lawlor MW. Common Data Elements for Muscle Biopsy Reporting. Archives of Pathology & Laboratory Medicine. PMID 26132600 DOI: 10.5858/arpa.2014-0453-OA |
0.365 |
|
| 2015 |
Li F, Buck D, De Winter J, Kolb J, Meng H, Birch C, Slater R, Escobar YN, Smith JE, Yang L, Konhilas J, Lawlor MW, Ottenheijm C, Granzier HL. Nebulin deficiency in adult muscle causes sarcomere defects and muscle-type dependent changes in trophicity--novel insights in nemaline myopathy. Human Molecular Genetics. PMID 26123491 DOI: 10.1093/Hmg/Ddv243 |
0.453 |
|
| 2015 |
Konersman CG, Bordini BJ, Scharer G, Lawlor MW, Zangwill S, Southern JF, Amos L, Geddes GC, Kliegman R, Collins MP. BAG3 myofibrillar myopathy presenting with cardiomyopathy. Neuromuscular Disorders : Nmd. 25: 418-22. PMID 25728519 DOI: 10.1016/j.nmd.2015.01.009 |
0.34 |
|
| 2015 |
Mack DL, Poulard K, Goddard M, Snyder JM, Grange RW, Doering J, Czerniecki S, Strande JL, Latournerie V, Veron P, Meng H, Yang L, Liu F, Le Bec C, Buscara L, ... ... Lawlor MW, et al. 503. Minimally Effective Dose of Systemic AAV8-MTM1 Needed To Prolong Survival and Correct Severe Muscle Pathology in a Canine Model of X-Linked Myotubular Myopathy Molecular Therapy. 23: S201. DOI: 10.1016/S1525-0016(16)34112-0 |
0.549 |
|
| 2014 |
Dowling JJ, Lawlor MW, Dirksen RT. Triadopathies: an emerging class of skeletal muscle diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 773-85. PMID 25168790 DOI: 10.1007/S13311-014-0300-3 |
0.437 |
|
| 2014 |
Meng H, Janssen PM, Grange RW, Yang L, Beggs AH, Swanson LC, Cossette SA, Frase A, Childers MK, Granzier H, Gussoni E, Lawlor MW. Tissue triage and freezing for models of skeletal muscle disease. Journal of Visualized Experiments : Jove. PMID 25078247 DOI: 10.3791/51586 |
0.597 |
|
| 2014 |
Lawlor MW, Viola MG, Meng H, Edelstein RV, Liu F, Yan K, Luna EJ, Lerch-Gaggl A, Hoffmann RG, Pierson CR, Buj-Bello A, Lachey JL, Pearsall S, Yang L, Hillard CJ, et al. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. The American Journal of Pathology. 184: 1831-42. PMID 24726641 DOI: 10.1016/J.Ajpath.2014.03.003 |
0.618 |
|
| 2014 |
Childers MK, Joubert R, Poulard K, Moal C, Grange RW, Doering JA, Lawlor MW, Rider BE, Jamet T, Danièle N, Martin S, Rivière C, Soker T, Hammer C, Van Wittenberghe L, et al. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy. Science Translational Medicine. 6: 220ra10. PMID 24452262 DOI: 10.1126/Scitranslmed.3007523 |
0.612 |
|
| 2013 |
Wu MP, Doyle JR, Barry B, Beauvais A, Rozkalne A, Piao X, Lawlor MW, Kopin AS, Walsh CA, Gussoni E. G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo. The Febs Journal. 280: 6097-113. PMID 24102982 DOI: 10.1111/Febs.12529 |
0.448 |
|
| 2013 |
Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, Schmitz-Abe K, DeChene ET, Swanson LC, Soemedi R, Vasli N, Iannaccone ST, Shieh PB, Shur N, Dennison JM, Lawlor MW, Laporte J, Markianos K, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 81: 1205-14. PMID 23975875 DOI: 10.1212/Wnl.0B013E3182A6Ca62 |
0.701 |
|
| 2013 |
Ottenheijm CA, Buck D, de Winter JM, Ferrara C, Piroddi N, Tesi C, Jasper JR, Malik FI, Meng H, Stienen GJ, Beggs AH, Labeit S, Poggesi C, Lawlor MW, Granzier H. Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy. Brain : a Journal of Neurology. 136: 1718-31. PMID 23715096 DOI: 10.1093/Brain/Awt113 |
0.662 |
|
| 2013 |
de Winter JM, Buck D, Hidalgo C, Jasper JR, Malik FI, Clarke NF, Stienen GJ, Lawlor MW, Beggs AH, Ottenheijm CA, Granzier H. Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations. Journal of Medical Genetics. 50: 383-92. PMID 23572184 DOI: 10.1136/Jmedgenet-2012-101470 |
0.651 |
|
| 2013 |
Moghadaszadeh B, Rider BE, Lawlor MW, Childers MK, Grange RW, Gupta K, Boukedes SS, Owen CA, Beggs AH. Selenoprotein N deficiency in mice is associated with abnormal lung development. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 1585-99. PMID 23325319 DOI: 10.1096/Fj.12-212688 |
0.748 |
|
| 2013 |
Lawlor MW, Armstrong D, Viola MG, Widrick JJ, Meng H, Grange RW, Childers MK, Hsu CP, O'Callaghan M, Pierson CR, Buj-Bello A, Beggs AH. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Human Molecular Genetics. 22: 1525-38. PMID 23307925 DOI: 10.1093/Hmg/Ddt003 |
0.634 |
|
| 2013 |
Amburgey K, Lawlor MW, Del Gaudio D, Cheng YW, Fitzpatrick C, Minor A, Li X, Aughton D, Das S, Beggs AH, Dowling JJ. Large duplication in MTM1 associated with myotubular myopathy. Neuromuscular Disorders : Nmd. 23: 214-8. PMID 23273872 DOI: 10.1016/J.Nmd.2012.11.010 |
0.542 |
|
| 2013 |
Dastgir J, Rutkowski A, Alvarez R, Cossette S, Yan K, Hoffmann R, Sewry C, Hayashi Y, Moore S, Goebel H, Bonnemann C, Lawlor M. P.10.18 Common data elements for muscle biopsy reporting Neuromuscular Disorders. 23: 794. DOI: 10.1016/J.Nmd.2013.06.548 |
0.323 |
|
| 2013 |
Ottenheijm C, Buck D, de Winter J, Lawlor M, Stienen G, Beggs A, Labeit S, Granzier H. A Novel Mouse Model of Nebulin-Based Nemaline Myopathy Biophysical Journal. 104: 38a. DOI: 10.1016/J.Bpj.2012.11.246 |
0.643 |
|
| 2012 |
Lawlor MW, Alexander MS, Viola MG, Meng H, Joubert R, Gupta V, Motohashi N, Manfready RA, Hsu CP, Huang P, Buj-Bello A, Kunkel LM, Beggs AH, Gussoni E. Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment. The American Journal of Pathology. 181: 961-8. PMID 22841819 DOI: 10.1016/J.Ajpath.2012.05.016 |
0.72 |
|
| 2012 |
Pierson CR, Dulin-Smith AN, Durban AN, Marshall ML, Marshall JT, Snyder AD, Naiyer N, Gladman JT, Chandler DS, Lawlor MW, Buj-Bello A, Dowling JJ, Beggs AH. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Human Molecular Genetics. 21: 811-25. PMID 22068590 DOI: 10.1093/Hmg/Ddr512 |
0.582 |
|
| 2012 |
Pratt SJ, Lawlor MW, Shah SB, Lovering RM. An in vivo rodent model of contraction-induced injury in the quadriceps muscle. Injury. 43: 788-93. PMID 22001505 DOI: 10.1016/J.Injury.2011.09.015 |
0.392 |
|
| 2011 |
Lawlor MW, Ottenheijm CA, Lehtokari VL, Cho K, Pelin K, Wallgren-Pettersson C, Granzier H, Beggs AH. Novel mutations in NEB cause abnormal nebulin expression and markedly impaired muscle force generation in severe nemaline myopathy. Skeletal Muscle. 1: 23. PMID 21798101 DOI: 10.1186/2044-5040-1-23 |
0.655 |
|
| 2011 |
Ottenheijm CA, Lawlor MW, Stienen GJ, Granzier H, Beggs AH. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Human Molecular Genetics. 20: 2015-25. PMID 21357678 DOI: 10.1093/Hmg/Ddr084 |
0.631 |
|
| 2011 |
Lawlor MW, Read BP, Edelstein R, Yang N, Pierson CR, Stein MJ, Wermer-Colan A, Buj-Bello A, Lachey JL, Seehra JS, Beggs AH. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. The American Journal of Pathology. 178: 784-93. PMID 21281811 DOI: 10.1016/J.Ajpath.2010.10.035 |
0.617 |
|
| 2010 |
Markert CD, Meaney MP, Voelker KA, Grange RW, Dalley HW, Cann JK, Ahmed M, Bishwokarma B, Walker SJ, Yu SX, Brown M, Lawlor MW, Beggs AH, Childers MK. Functional muscle analysis of the Tcap knockout mouse. Human Molecular Genetics. 19: 2268-83. PMID 20233748 DOI: 10.1093/Hmg/Ddq105 |
0.66 |
|
| 2010 |
Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Human Mutation. 31: 176-83. PMID 19953533 DOI: 10.1002/Humu.21157 |
0.736 |
|
| 2008 |
Lawlor MW, Nielsen GP, Louis DN. Malignant solitary fibrous tumour of the meninges with marked amianthoid fibre deposition. Neuropathology and Applied Neurobiology. 34: 569-72. PMID 18298634 DOI: 10.1111/J.1365-2990.2008.00943.X |
0.354 |
|
| Show low-probability matches. |